Valproic Acid and Its Amidic Derivatives as New Antivirals against Alphaherpesviruses.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
26 11 2020
Historique:
received: 14 11 2020
revised: 24 11 2020
accepted: 25 11 2020
entrez: 1 12 2020
pubmed: 2 12 2020
medline: 27 2 2021
Statut: epublish

Résumé

Herpes simplex viruses (HSVs) are neurotropic viruses with broad host range whose infections cause considerable health problems in both animals and humans. In fact, 67% of the global population under the age of 50 are infected with HSV-1 and 13% have clinically recurrent HSV-2 infections. The most prescribed antiherpetics are nucleoside analogues such as acyclovir, but the emergence of mutants resistant to these drugs and the lack of available vaccines against human HSVs has led to an imminent need for new antivirals. Valproic acid (VPA) is a branched short-chain fatty acid clinically used as a broad-spectrum antiepileptic drug in the treatment of neurological disorders, which has shown promising antiviral activity against some herpesviruses. Moreover, its amidic derivatives valpromide and valnoctamide also share this antiherpetic activity. This review summarizes the current research on the use of VPA and its amidic derivatives as alternatives to traditional antiherpetics in the fight against HSV infections.

Identifiants

pubmed: 33256172
pii: v12121356
doi: 10.3390/v12121356
pmc: PMC7760627
pii:
doi:

Substances chimiques

Amides 0
Antiviral Agents 0
Valproic Acid 614OI1Z5WI

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Antiviral Res. 2019 Aug;168:91-99
pubmed: 31132386
J Control Release. 1999 Nov 1;62(1-2):187-92
pubmed: 10518650
Curr Opin Neurol. 2003 Apr;16(2):203-11
pubmed: 12644750
Proc Natl Acad Sci U S A. 2019 Dec 10;:
pubmed: 31822620
J Neurovirol. 2005 Apr;11(2):190-8
pubmed: 16036797
Adv Pharmacol. 2013;67:1-38
pubmed: 23885997
Lancet Neurol. 2016 Feb;15(2):210-218
pubmed: 26655849
Neurotherapeutics. 2007 Jan;4(1):130-7
pubmed: 17199028
Ann Dermatol Venereol. 2002 May;129(5 Pt 1):708-15
pubmed: 12124513
Virology. 2016 Dec;499:121-135
pubmed: 27657833
Handb Clin Neurol. 2014;123:251-63
pubmed: 25015489
mBio. 2016 Mar 01;7(2):e00113
pubmed: 26933051
Antivir Ther. 2016;21(4):277-86
pubmed: 26726828
Bipolar Disord. 2010 Jun;12(4):376-82
pubmed: 20636634
Curr Opin Infect Dis. 2016 Dec;29(6):654-662
pubmed: 27306564
Epidemiol Infect. 2017 Oct;145(13):2666-2677
pubmed: 28826422
Viruses. 2019 May 17;11(5):
pubmed: 31108875
Profiles Drug Subst Excip Relat Methodol. 2018;43:1-208
pubmed: 29678260
J Virol. 2011 Feb;85(3):1267-74
pubmed: 21106740
Vaccine. 2016 Jun 3;34(26):2948-2952
pubmed: 26973067
Int J Mol Sci. 2017 Sep 06;18(9):
pubmed: 28878165
Pharmacol Biochem Behav. 2018 Apr;167:17-28
pubmed: 29452136
Int J Mol Sci. 2020 Jul 16;21(14):
pubmed: 32708697
Arch Virol. 2009;154(1):171-7
pubmed: 19066710
J Biomed Biotechnol. 2010;2010:
pubmed: 20798865
J Hum Genet. 2017 Dec;62(12):1009-1014
pubmed: 28878340
PLoS One. 2014 Feb 13;9(2):e89141
pubmed: 24551233
Adv Exp Med Biol. 2018;1045:103-122
pubmed: 29896665
Viruses. 2018 Nov 02;10(11):
pubmed: 30400213
Clin Biochem. 2013 Oct;46(15):1323-38
pubmed: 23792104
J Antimicrob Chemother. 1997 Feb;39(2):119-28
pubmed: 9069530
Br J Pharmacol. 2005 Sep;146(2):198-208
pubmed: 15997234
Reprod Toxicol. 2009 Jul;28(1):1-10
pubmed: 19490988
Neuropharmacology. 2010 Jun;58(8):1228-36
pubmed: 20230843
J Neurosci. 2017 Jul 19;37(29):6877-6893
pubmed: 28630251
Cochrane Database Syst Rev. 2013 Jun 24;(6):CD010611
pubmed: 23797677
J Obstet Gynecol Neonatal Nurs. 1986 Mar-Apr;15(2):111-6
pubmed: 3084732
Virus Res. 2016 Mar 2;214:71-9
pubmed: 26805038
Epilepsy Behav. 2015 Aug;49:298-302
pubmed: 25979572
Antiviral Res. 2013 Aug;99(2):172-9
pubmed: 23735299
Vet J. 2016 Jan;207:38-44
pubmed: 26654843
Pharm World Sci. 1994 Feb 18;16(1):2-6
pubmed: 8156045
Adv Drug Deliv Rev. 2012 Jul;64(10):887-95
pubmed: 22210279
Biochemistry (Mosc). 2014 Dec;79(13):1635-52
pubmed: 25749169
Adv Exp Med Biol. 2018;1045:63-84
pubmed: 29896663
Pharmacogenet Genomics. 2013 Apr;23(4):236-41
pubmed: 23407051
Birth Defects Res. 2019 Aug 15;111(14):1013-1023
pubmed: 30325584
Pharm Res. 2003 Aug;20(8):1293-301
pubmed: 12948028
J Clin Med. 2019 Sep 11;8(9):
pubmed: 31514402
Neural Regen Res. 2018 Feb;13(2):211-221
pubmed: 29557362
Clin Infect Dis. 2004 Nov 1;39 Suppl 5:S248-57
pubmed: 15494896
Birth Defects Res B Dev Reprod Toxicol. 2004 Feb;71(1):47-53
pubmed: 14991910
Clin Pharmacokinet. 1991 Feb;20(2):114-22
pubmed: 2029804
Curr Opin Infect Dis. 2015 Dec;28(6):589-95
pubmed: 26524331
Am Fam Physician. 2016 Jun 1;93(11):928-34
pubmed: 27281837
Ther Drug Monit. 2018 Oct;40(5):526-548
pubmed: 29957667
Vet Q. 2013 Jun;33(2):68-81
pubmed: 23802762
Curr Pain Headache Rep. 2017 Jul;21(7):33
pubmed: 28551737
Brain Res Bull. 1994;33(3):333-6
pubmed: 7904890
Int J Oral Sci. 2016 Mar 30;8(1):1-6
pubmed: 27025259
Psychiatry Res. 2017 Aug;254:279-283
pubmed: 28500975
Epilepsia. 2017 Feb;58(2):181-221
pubmed: 28111749
J Am Acad Dermatol. 1988 Jan;18(1 Pt 2):176-9
pubmed: 2828440
Mol Psychiatry. 2002;7(7):726-33
pubmed: 12192617
Eur J Clin Pharmacol. 1990;38(3):289-91
pubmed: 2111246

Auteurs

Sabina Andreu (S)

Departamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain.
Centro de Biología Molecular Severo Ochoa, Spanish National Research Council-Universidad Autónoma de Madrid (CSIC-UAM), Cantoblanco, 28049 Madrid, Spain.

Inés Ripa (I)

Departamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain.
Centro de Biología Molecular Severo Ochoa, Spanish National Research Council-Universidad Autónoma de Madrid (CSIC-UAM), Cantoblanco, 28049 Madrid, Spain.

Raquel Bello-Morales (R)

Departamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain.
Centro de Biología Molecular Severo Ochoa, Spanish National Research Council-Universidad Autónoma de Madrid (CSIC-UAM), Cantoblanco, 28049 Madrid, Spain.

José Antonio López-Guerrero (JA)

Departamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain.
Centro de Biología Molecular Severo Ochoa, Spanish National Research Council-Universidad Autónoma de Madrid (CSIC-UAM), Cantoblanco, 28049 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH